share_log

Eloxx Pharmaceuticals Q2 EPS $(1.96) Misses $(1.54) Estimate

Eloxx Pharmaceuticals Q2 EPS $(1.96) Misses $(1.54) Estimate

Eloxx Pharmicals 第二季度每股收益 (1.96) 未達到預期 (1.54)
Benzinga ·  2023/08/14 08:43

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(1.96) per share which missed the analyst consensus estimate of $(1.54) by 27.27 percent. This is a 1533.33 percent decrease over losses of $(0.12) per share from the same period last year.

Eloxx Pharmicals(納斯達克股票代碼:ELOX)公佈的季度每股虧損爲1.96美元,比分析師普遍預期的1.54美元(1.54美元)低27.27%。這比去年同期的每股虧損(0.12美元)減少了1533.33%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論